156 related articles for article (PubMed ID: 10814209)
1. Synthesis of cryptophycin 52 using the sharpless asymmetric dihydroxylation: diol to epoxide transformation optimized for a base-sensitive substrate.
Liang J; Moher ED; Moore RE; Hoard DW
J Org Chem; 2000 May; 65(10):3143-7. PubMed ID: 10814209
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of cryptophycin 52 using the Shi epoxidation.
Hoard DW; Moher ED; Martinelli MJ; Norman BH
Org Lett; 2002 May; 4(10):1813-5. PubMed ID: 12000306
[TBL] [Abstract][Full Text] [Related]
3. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
Eissler S; Bogner T; Nahrwold M; Sewald N
Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
[TBL] [Abstract][Full Text] [Related]
4. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
5. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective synthesis of (+)-cryptophycin 52 (LY355703), a potent antimitotic antitumor agent.
Ghosh AK; Swanson L
J Org Chem; 2003 Dec; 68(25):9823-6. PubMed ID: 14656116
[TBL] [Abstract][Full Text] [Related]
7. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
Shih C; Teicher BA
Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
[TBL] [Abstract][Full Text] [Related]
8. Conformationally constrained analogues of diacylglycerol. 24. Asymmetric synthesis of a chiral (R)-DAG-lactone template as a versatile precursor for highly functionalized DAG-lactones.
Kang JH; Siddiqui MA; Sigano DM; Krajewski K; Lewin NE; Pu Y; Blumberg PM; Lee J; Marquez VE
Org Lett; 2004 Jul; 6(14):2413-6. PubMed ID: 15228292
[TBL] [Abstract][Full Text] [Related]
9. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
[TBL] [Abstract][Full Text] [Related]
10. Three new cryptophycins from Nostoc sp. GSV 224.
Subbaraju GV; Golakoti T; Patterson GM; Moore RE
J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
[TBL] [Abstract][Full Text] [Related]
11. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
12. Preclinical anticancer activity of cryptophycin-8.
Corbett TH; Valeriote FA; Demchik L; Polin L; Panchapor C; Pugh S; White K; Knight J; Jones J; Jones L; LoRusso P; Foster B; Wiegand RA; Lisow L; Golakoti T; Heltzel CE; Ogino J; Patterson GM; Moore RE
J Exp Ther Oncol; 1996 Mar; 1(2):95-108. PubMed ID: 9414393
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative mechanism of action of cryptophycin-52: kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends.
Panda D; DeLuca K; Williams D; Jordan MA; Wilson L
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9313-8. PubMed ID: 9689077
[TBL] [Abstract][Full Text] [Related]
14. Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.
Kumar VP; Chandrasekhar S
Org Lett; 2013 Jul; 15(14):3610-3. PubMed ID: 23822896
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of macromolecular synthesis by cryptophycin-52.
Subramanian B; Nakeff A; Media JE; Wiegand RA; Valeriote FA
Anticancer Drugs; 2002 Nov; 13(10):1061-8. PubMed ID: 12439340
[TBL] [Abstract][Full Text] [Related]
16. Diversity-oriented asymmetric synthesis of hapalosin: construction of three small C9/C4/C3-modified hapalosin analogue libraries.
Dai CF; Cheng F; Xu HC; Ruan YP; Huang PQ
J Comb Chem; 2007; 9(3):386-94. PubMed ID: 17358084
[TBL] [Abstract][Full Text] [Related]
17. De novo asymmetric syntheses of D- and L-talose via an iterative dihydroxylation of dienoates.
Ahmed MM; O'Doherty GA
J Org Chem; 2005 Dec; 70(25):10576-8. PubMed ID: 16323875
[TBL] [Abstract][Full Text] [Related]
18. De novo asymmetric syntheses of C-4-substituted sugars via an iterative dihydroxylation strategy.
Ahmed MM; O'Doherty GA
Carbohydr Res; 2006 Jul; 341(10):1505-21. PubMed ID: 16616898
[TBL] [Abstract][Full Text] [Related]
19. Total synthesis of antitumor depsipeptide (-)-doliculide.
Ghosh AK; Liu C
Org Lett; 2001 Feb; 3(4):635-8. PubMed ID: 11178844
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of γ-monofluorinated goniothalamin analogues via regio- and stereoselective ring-opening hydrofluorination of epoxide.
Chen JL; Zheng F; Huang Y; Qing FL
J Org Chem; 2011 Aug; 76(16):6525-33. PubMed ID: 21739972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
